Literature DB >> 9385348

The relationship between fibromyalgia and the multiple chemical sensitivity syndrome.

A T Slotkoff1, D A Radulovic, D J Clauw.   

Abstract

Fibromyalgia (FM) patients often report a high frequency of non-musculoskeletal symptoms, including those suggestive of multiple chemical sensitivity (MCS) syndrome. The objective of this pilot study was to determine the prevalence of MCS in FM patients from a university-based rheumatology practice. Self-report questionnaires were administered to determine the presence of MCS, utilizing the criteria from a recent study of the immunologic profile of patients with this disorder. Patients also responded "yes" or "no" to the presence of 48 FM-related symptoms. Thirty-three of 60 patients with FM met the criteria for MCS. Eleven of these patients also fulfilled more restrictive criteria, requiring a "higher degree" of chemical sensitivity. The symptoms and substances most frequently cited were similar to those reported in other studies of MCS. FM patients with and without MCS did not differ in other symptomatology. MCS may represent an additional symptom complex within the spectrum of FM.

Entities:  

Mesh:

Year:  1997        PMID: 9385348     DOI: 10.3109/03009749709065700

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  9 in total

1.  Chemical intolerance in primary care settings: prevalence, comorbidity, and outcomes.

Authors:  David A Katerndahl; Iris R Bell; Raymond F Palmer; Claudia S Miller
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

Review 2.  Epidemiology of fibromyalgia.

Authors:  Lily Neumann; Dan Buskila
Journal:  Curr Pain Headache Rep       Date:  2003-10

3.  Celiac symptoms in patients with fibromyalgia: a cross-sectional study.

Authors:  Juan Miguel García-Leiva; Jorge Luis Ordóñez Carrasco; Mahmoud Slim; Elena P Calandre
Journal:  Rheumatol Int       Date:  2014-08-15       Impact factor: 2.631

Review 4.  Multiple chemical sensitivity: a review of the theoretical and research literature.

Authors:  X S Labarge; R J McCaffrey
Journal:  Neuropsychol Rev       Date:  2000-12       Impact factor: 7.444

5.  The FIBRO System: A Rapid Strategy for Assessment and Management of Fibromyalgia Syndrome.

Authors:  Chad S Boomershine
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

Review 6.  A symptom-based approach to pharmacologic management of fibromyalgia.

Authors:  Chad S Boomershine; Leslie J Crofford
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

7.  Duloxetine for the management of fibromyalgia syndrome.

Authors:  Beth A Scholz; Cara L Hammonds; Chad S Boomershine
Journal:  J Pain Res       Date:  2009-07-21       Impact factor: 3.133

Review 8.  Ocular neuropathic pain.

Authors:  Perry Rosenthal; David Borsook
Journal:  Br J Ophthalmol       Date:  2015-05-05       Impact factor: 4.638

9.  Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.

Authors:  Jarred W Younger; Alex J Zautra; Eric T Cummins
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.